One Size Doesn’t Fit All: Sick Children Deserve Health Research Designed for Them
This National Child Day, the Canadian Institutes of Health Research (CIHR) celebrates the Canadian scientists, clinicians and young patients working together to gather the evidence needed to develop better, safer treatments, tailored to children’s needs, today and in the future.
Op-ed by Dr. Christine Chambers
Published in the Hill Times, November 20, 2026
Chris, a new mom, arrives in the emergency department cradling her baby, Pete, whose small chest heaves as he struggles to breathe. He is pale and listless… almost floppy in her arms. The medical team diagnoses bronchiolitis, an acute viral infection that inflames the small airways in an infant’s lungs.
After three days of oxygen therapy and supportive care, Pete is well enough to go home. Despite this positive outcome, questions remain about what more could have been done to improve his treatment.
Pete’s experience is far from uncommon. In Canada, one in three children develop bronchiolitis before their second birthday, so it is important to ask if we are giving children the treatment that works best for them.
What if children’s hospitals across Canada could work together to answer that question and change how thousands of children receive emergency care?
Pediatric researchers from six Canadian emergency departments are doing just that through funding from CIHR’s Strategy for Patient-Oriented Research (SPOR) Innovative Clinical Trials Initiative. Bronchiolitis is one of four common childhood health emergencies they are studying. The goal is to reduce the amount of time needed to answer research questions, develop more effective ways to test medical treatments for children, and ultimately help doctors make better-informed treatment decisions for their young patients.
As Canada’s national funder of health research, CIHR invested in this initiative because children continue to be underrepresented in medical research. Up to 80% of medications prescribed to children are off-label, meaning their use differs from the dose, route of administration, patient age or medical indication approved by Health Canada. And only 13% of clinical trials include children.
One reason for this gap is because there aren’t enough children with a particular condition at one hospital to conduct a meaningful study. By bringing together doctors, researchers, patients and families from multiple hospitals, researchers can study more children, generate more reliable evidence, answer important medical questions faster and understand whether treatments work across different groups of young patients.
CIHR and Canadian families are seeing a positive return on this investment. Published in leading medical journals, the findings from these trials are already changing what we know about treating common childhood emergencies and provide physicians with stronger evidence to ensure children receive care tailor-made for them, while protecting them from unnecessary medications and side effects.
For example, the No OUCH study, one of the four innovative pediatric clinical trials, found that adding an oral opioid to ibuprofen did not provide better pain relief for children with arm or leg injuries that did not require surgery, contrary to previous beliefs. This cross-Canada study showed that ibuprofen (Advil) alone provided the same level of pain relief as ibuprofen and acetaminophen (Tylenol) or ibuprofen and hydromorphone (Dilaudid). In fact, the children treated with hydromorphone were four to five times more likely to experience dizziness, fatigue and nausea than those who just took ibuprofen. This evidence could change the way children with sprains and fractures are treated.
The DOSE-AGE trial involved 1,030 children treated in pediatric emergency departments for acute gastroenteritis (vomiting and diarrhea). It found that prescribing the anti-nausea medication ondansetron for use at home after discharge reduced the risk of moderate-to-severe gastroenteritis over the following week.
These studies are about more than finding better treatments, however, they are building the foundation for a stronger collaborative approach to children’s health research.
As we mark National Child Day, we must continue to invest in collaborative pediatric clinical trials. Developing partnerships and sharing research findings will further strengthen Canada’s reputation as an international leader in pediatric research. Most importantly, families like Pete’s, the little boy who struggled to breathe, are counting on our hospitals and researchers to work together to find the safest and most effective treatments, supported by evidence from research designed specifically for children. Collaborative research helps ensure that the questions that matter most to children and their families are answered through research that reflects their needs.
Dr. Christine Chambers
Scientific Director, CIHR Institute of Human Development, Child and Youth Health
- Date modified: